Bids Are Invited For Price Registration For Future And Installment Acquisition Of The Drug Cymbalta® 60 Mg (Duloxetine Hydrochloride) In Compliance With Judicial Determination

Tender Detail

100826882
117/2025
Self-Funded
Bids Are Invited For Price Registration For Future And Installment Acquisition Of The Drug Cymbalta® 60 Mg (Duloxetine Hydrochloride) In Compliance With Judicial Determination
NCB
South America
BRIC,G20
08-09-2025

Work Detail

Technical Description Of The Medication Commercial Name: Cymbalta® Generic Name: Duloxetine Hydrochloride Pharmaceutical Form: Delayed Release Capsules Dosage: 60 Mg Therapeutic Class: Selective Inhibitor Of Serotonin And Noradprenaline Reuptake (Irsn) Manufacturer: Eli Lilly Composition: Each Capsule Contains Duloxetine Hydrochloride Duloxetine Mg. Excipients: Hydroxypilmethylcellulose, Acetate Of Hydroxypropylmethylcellulose, Sucrose, Sugar Spheres, Talc, Titanium Dioxide And Trietyl Citrate. Physical Characteristics: Duloxetine Hydrochloride Is A Color Of Color That Varies From White To Slightly Brownish White. It Is Slightly Soluble In Water.

Key Value

Tender Value
Refer document

Attachment

FileName File Description
Global Tender Document Tender Notice
Attachments
Additional Details Available on Click
✓ Tendering Authority
✓ Publication Document
(Tender Document / Tender Notice )
Disclaimer :
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
Tell us about your Product / Services,
We will Find Tenders for you

Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

For Tender Information Services Visit : TenderDetail